Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM, Gratz S, Markus PM, Dunn RM, Hüfner M, Schauer A, Fischer M, Munz DL, Becker H, Becker W. Behr TM, et al. Among authors: gratz s. Cancer. 1997 Dec 15;80(12 Suppl):2436-57. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.3.co;2-3. Cancer. 1997. PMID: 9406695
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. Behr TM, et al. Among authors: gratz s. Int J Cancer. 1998 May 29;76(5):738-48. doi: 10.1002/(sici)1097-0215(19980529)76:5<738::aid-ijc20>3.0.co;2-z. Int J Cancer. 1998. PMID: 9610734
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Among authors: gratz s. Cancer Res. 1999 Jun 1;59(11):2635-43. Cancer Res. 1999. PMID: 10363986
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.
Behr TM, Griesinger F, Riggert J, Gratz S, Béhé M, Kaufmann CC, Wörmann B, Brittinger G, Becker W. Behr TM, et al. Among authors: gratz s. Cancer. 2002 Feb 15;94(4 Suppl):1363-72. doi: 10.1002/cncr.10307. Cancer. 2002. Retraction in: Cancer. 2005 Dec 15;104(12):2888. doi: 10.1002/cncr.21658. PMID: 11877767 Free article. Retracted. Clinical Trial.
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Behr TM, Liersch T, Greiner-Bechert L, Griesinger F, Béhé M, Markus PM, Gratz S, Angerstein C, Brittinger G, Becker H, Goldenberg DM, Becker W. Behr TM, et al. Among authors: gratz s. Cancer. 2002 Feb 15;94(4 Suppl):1373-81. doi: 10.1002/cncr.10308. Cancer. 2002. PMID: 11877768 Free article. Clinical Trial.
185 results